Twenty-five years of research on bovine lactoferrin applications

Biochimie

Volumn 91, Issue 1, 2009, Pages 52-57

  Tomita, Mamoru ^a   Wakabayashi, Hiroyuki ^b   Shin, Kouichirou ^b   Yamauchi, Koji ^b   Yaeshima, Tomoko ^b   Iwatsuki, Keiji ^b  

^a TechnoLiaison Inc   (Japan)

^b MORINAGA MILK INDUSTRY CO LTD   (Japan)

Author keywords

Bovine; Lactoferricin; Lactoferrin

Indexed keywords

LACTOFERRICIN; LACTOFERRICIN B; LACTOFERRICIN H; LACTOFERRIN; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTIFICIAL MILK; CANCER PREVENTION; COLON CARCINOGENESIS; COLORECTAL ADENOMA; DRUG MECHANISM; DRUG METABOLISM; GASTRITIS; HERPES VIRUS INFECTION; INTESTINE FLORA; PNEUMONIA; REVIEW; THRUSH; URINARY TRACT INFECTION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFECTIVE AGENTS; CATTLE; HUMANS; INTESTINES; LACTOFERRIN;

BOVINAE;

EID: 58149127827     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2008.05.021     Document Type: Review

References (75)

1. Sørensen M., and Sørensen S.P.L. The proteins in whey. C. R. Trav. Lab. Carlsberg 23 (1939) 55-99
2. Groves M.L. The isolation of a red protein from milk. J. Am. Chem. Soc. 82 (1960) 3345-3350
3. Johansson B. Isolation of an iron containing red protein from human milk. Acta Chem. Scand. 14 (1960) 510-512
4. Montreuil J., Tonnelat J., and Mullet S. Preparation and properties of lactosiderophilin (lactotransferrin) of human milk. Biochim. Biophys. Acta 45 (1960) 413-421 (in French)
5. Arnold R.R., Cole M.F., and McGhee J.R. A bactericidal effect for human lactoferrin. Science 197 (1977) 263-265
6. Broxmeyer H.E., Smithyman A., Egar R.R., Meyers P.A., and DeSousa M. Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production. J. Exp. Med. 148 (1978) 1052-1067
7. Spik G., Strecker G., Fournet B., Bouquelet S., Montreuil J., Dorland L., Van Halbeek H., and Vliegenthart J.F.G. Primary structure of the glycans from human lactotransferrin. Eur. J. Biochem. 121 (1982) 413-419
8. Levay P.F., and Viljoen M. Lactoferrin: a general review. Haematologica 80 (1995) 252-267
9. Lönnerdal B., and Iyer S. Lactoferrin: molecular structure and biological function. Annu. Rev. Nutr. 15 (1995) 93-110
10. Shimazaki K. Lactoferrin: a marvelous protein in milk?. J. Anim. Sci. 71 (2000) 329-347
11. Chierici R. Antimicrobial actions of lactoferrin. Adv. Nutr. Res. 10 (2001) 247-269
12. Wakabayashi H., Yamauchi K., and Takase M. Lactoferrin research, technology and applications. Int. Dairy J. 16 (2006) 1241-1251
13. Wakabayashi H., Takase M., and Tomita M. Lactoferricin derived from milk protein lactoferrin. Curr. Pharm. Des. 9 (2003) 1277-1287
14. Y. Tamura, Production and application of bovine lactoferrin, in: Bulletin of the International Dairy Federation 389-Bruges 2003, Advances in Fractionation and Separation: Processes for Novel Dairy Applications, 2004, pp. 64-68.
15. Kawaguchi S., Hayashi T., Masano J., Okuyama K., Suzuki T., and Kawase K. A study concerning the effect of lactoferrin-enriched infant formula on low birth weight infants. Perinat. Med. 19 (1989) 557-562 (in Japanese)
16. Roberts A.K., Chierici R., Sawatzki G., Hill M.J., Volpato S., and Vigi V. Supplementation of an adapted formula with bovine lactoferrin: 1. Effect on the infant faecal flora. Acta Paediatr. 81 (1992) 119-124
17. Chierici R., Sawatzki G., Tamisari L., Volpato S., and Vigi V. Supplementation of an adapted formula with bovine lactoferrin: 2. Effects on serum iron, ferritin and zinc levels. Acta Paediatr. 81 (1992) 475-479
18. King Jr. J.C., Cummings G.E., Guo N., Trivedi L., Readmond B.X., Keane V., Feigelman S., and de Waard R. A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants. J. Pediatr. Gastroenterol. Nutr. 44 (2007) 245-251
19. Satué-Gracia M.T., Frankel E.N., Rangavajhyala H., and German J.B. Lactoferrin in infant formulas: effect on oxidation. J. Agric. Food Chem. 48 (2000) 4984-4990
20. Egashira M., Takayanagi T., Moriuchi M., and Moriuchi H. Does daily intake of bovine lactoferrin-containing products ameliorate rotaviral gastroenteritis?. Acta Paediatr. 96 (2007) 1238-1244
21. Ishii K., Takamura N., Shinohara M., Wakui N., Shin H., Sumino Y., Ohmoto Y., Teraguchi S., and Yamauchi K. Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months. Hepatol. Res. 25 (2003) 226-233
22. Okuda M., Nakazawa T., Yamauchi K., Miyashiro E., Koizumi R., Booka M., Teraguchi S., Tamura Y., Yoshikawa N., Adachi Y., and Imoto I. Bovine lactoferrin is effective to suppress Helicobacter pylori colonization in the human stomach: a randomized, double-blind, placebo-controlled study. J. Infect. Chemother. 11 (2005) 265-269
23. Masada S., Yamane Y., Shimoda K., Shimoda T., Nakaniwa S., Uno T., Hirose T., Ishikawa K., Kijima M., and Yonezawa H. Clinical use of SK-1 for dermatotherapy in dogs and cats. J. Anim. Clin. Res. Found. 3 (1995) 37-43 (in Japanese)
24. Balmer S.E., Scott P.H., and Wharton B.A. Diet and faecal flora in the newborn: lactoferrin. Arch. Dis. Child. 64 (1989) 1685-1690
25. Teraguchi S., Ozawa K., Yasuda S., Shin K., Fukuwatari Y., and Shimamura S. The bacteriostatic effects of orally administered bovine lactoferrin on intestinal Enterobacteriaceae of SPF mice fed bovine milk. Biosci. Biotechnol. Biochem. 58 (1994) 482-487
26. Teraguchi S., Shin K., Ogata T., Kingaku M., Kaino A., Miyauchi H., Fukuwatari Y., and Shimamura S. Orally administered bovine lactoferrin inhibits bacterial translocation in mice fed bovine milk. Appl. Environ. Microbiol. 61 (1995) 4131-4134
27. Wakabayashi H., Uchida K., Yamauchi K., Teraguchi S., Hayasawa H., and Yamaguchi H. Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models. J. Antimicrob. Chemother. 46 (2000) 595-601
28. Wakabayashi H., Kurokawa M., Shin K., Teraguchi S., Tamura Y., and Shiraki K. Oral lactoferrin prevents body weight loss and increases cytokine responses during herpes simplex virus type 1 infection of mice. Biosci. Biotechnol. Biochem. 68 (2004) 537-544
29. Takakura N., Wakabayashi H., Ishibashi H., Teraguchi S., Tamura Y., Yamaguchi H., and Abe S. Oral lactoferrin treatment of experimental oral candidiasis in mice. Antimicrob. Agents Chemother. 47 (2003) 2619-2623
30. Shin K., Wakabayashi H., Yamauchi K., Teraguchi S., Tamura Y., Kurokawa M., and Shiraki K. Effects of orally administered bovine lactoferrin and lactoperoxidase on influenza virus infection in mice. J. Med. Microbiol. 54 (2005) 717-723
31. Tanaka K., Ikeda M., Nozaki A., Kato N., Tsuda H., Saito S., and Sekihara H. Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study. Jpn. J. Cancer Res. 90 (1999) 367-371
32. Yamauchi K., Hiruma M., Yamazaki N., Wakabayashi H., Kuwata H., Teraguchi S., Hayasawa H., Suegara N., and Yamaguchi H. Oral administration of bovine lactoferrin for treatment of tinea pedis. A placebo-controlled, double-blind study. Mycoses 43 (2000) 197-202
33. Di Mario F., Aragona G., Dal Bò N., Cavestro G.M., Cavallaro L., Iori V., Comparato G., Leandro G., Pilotto A., and Franzè A. Use of bovine lactoferrin for Helicobacter pylori eradication. Dig. Liver Dis. 35 (2003) 706-710
34. Sekine K., Ushida Y., Kuhara T., Iigo M., Baba-Toriyama H., Moore M.A., Murakoshi M., Satomi Y., Nishino H., Kakizoe T., and Tsuda H. Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. Cancer Lett. 121 (1997) 211-216
35. Tsuda H., Sekine K., Fujita K., and Iigo M. Cancer prevention by bovine lactoferrin and underlying mechanisms - a review of experimental and clinical studies. Biochem. Cell Biol. 80 (2002) 131-136
36. Iigo M., Kuhara T., Ushida Y., Sekine K., Moore M.A., and Tsuda H. Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin. Exp. Metastasis 17 (1999) 35-40
37. T. Kozu, Y. Saito, T. Matsuda, T. Akasu, G. Iinuma, Y. Ohashi, D. Saito, H. Tsuda, M. Iigo, T. Kakizoe, The efficacy of lactoferrin for suppression of colorectal adenomas, in: Proceedings of Sixty-fifth Annual Meeting of the Japanese Cancer Association, 2006, 461 pp. (in Japanese).
38. Kuwata H., Yamauchi K., Teraguchi S., Ushida Y., Shimokawa Y., Toida T., and Hayasawa H. Functional fragments of ingested lactoferrin are resistant to proteolytic degradation in the gastrointestinal tract of adult rats. J. Nutr. 131 (2001) 2121-2127
39. Wakabayashi H., Kuwata H., Yamauchi K., Teraguchi S., and Tamura Y. No detectable transfer of dietary lactoferrin or its functional fragments to portal blood in healthy adult rats. Biosci. Biotechnol. Biochem. 68 (2004) 853-860
40. Teraguchi S., Wakabayashi H., Kuwata H., Yamauchi K., and Tamura Y. Protection against infections by oral lactoferrin: evaluation in animal models. Biometals 17 (2004) 231-234
41. Kuhara T., Iigo M., Itoh T., Ushida Y., Sekine K., Terada N., Okamura H., and Tsuda H. Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium. Nutr. Cancer 38 (2000) 192-199
42. Takakura N., Wakabayashi H., Yamauchi K., and Takase M. Influences of orally administered lactoferrin on IFN-γ and IL-10 production by intestinal intraepithelial lymphocytes and mesenteric lymph-node cells. Biochem. Cell Biol. 84 (2006) 363-368
43. Wang W.P., Iigo M., Sato J., Sekine K., Adachi I., and Tsuda H. Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin. Jpn. J. Cancer Res. 91 (2000) 1022-1027
44. Wakabayashi H., Takakura N., Yamauchi K., and Tamura Y. Modulation of immunity-related gene expression in small intestines of mice by oral administration of lactoferrin. Clin. Vaccine Immunol. 13 (2006) 239-245
45. Wakabayashi H., Takakura N., Teraguchi S., and Tamura Y. Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans. Microbiol. Immunol. 47 (2003) 37-43
46. Takakura N., Wakabayashi H., Ishibashi H., Yamauchi K., Teraguchi S., Tamura Y., Yamaguchi H., and Abe S. Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. J. Med. Microbiol. 54 (2004) 495-500
47. Suzuki Y.A., Shin K., and Lönnerdal B. Molecular cloning and functional expression of a human intestinal lactoferrin receptor. Biochemistry 40 (2001) 15771-15779
48. Spadaro M., Caorsi C., Ceruti P., Varadhachary A., Forni G., Pericle F., and Giovarelli M. Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells. FASEB J. (2008) doi:10.1096/fj.07-098038.
49. de la Rosa G., Yang D., Tewary P., Varadhachary A., and Oppenheim J.J. Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. J. Immunol. 180 (2008) 6868-6876
50. Groot F., Geijtenbeek T.B.H., Sanders R.W., Baldwin C.E., Sanchez-Hernandez M., Floris R., van Kooyk Y., de Jong E.C., and Berkhout B. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN-gp120 interaction. J. Virol. 79 (2005) 3009-3015
51. Legrand D., Mazurier J., Elass A., Rochard E., Vergoten G., Maes P., Montreuil J., and Spik G. Molecular interaction between human lactotransferrin and the phytohemagglutinin-activated human lymphocyte lactotransferrin receptor line in two loop-containing regions of the N-terminal domain I of human lactotransferrin. Biochemistry 31 (1992) 9243-9251
52. Tanaka T., Morita H., Yoo Y., Kim W., kumura H., and Shimazaki K. Detection of bovine lactoferrin binding protein on Jurkat human lymphoblastic T cell line. J. Vet. Med. Sci. 66 (2004) 865-869
53. Tomita M., Bellamy W., Takase M., Yamauchi K., Wakabayashi H., and Kawase K. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J. Dairy Sci. 74 (1991) 4137-4142
54. Bellamy W., Takase M., Yamauchi K., Wakabayashi H., Kawase K., and Tomita M. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1121 (1992) 130-136
55. Kuwata H., Yip T.T., Tomita M., and Hutchens T.W. Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. Biochim. Biophys. Acta 1429 (1998) 129-141
56. Tomita M., Takase M., Bellamy W., and Shimamura S. A review: the active peptide of lactoferrin. Acta Paediatr. Jpn. 36 (1994) 585-591
57. Vogel H.J., Schibli D.J., Jing W., Lohmeier-Vogel E.M., Epand R.F., and Epand R.M. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem. Cell Biol. 80 (2002) 49-63
58. Gifford J.L., Hunter H.N., and Vogel H.J. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell. Mol. Life Sci. 62 (2005) 2588-2598
59. Tomita M., Wakabayashi H., Yamauchi K., Teraguchi S., and Hayasawa H. Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochem. Cell Biol. 80 (2002) 109-112
60. Jenssen H., Hamill P., and Hancock R.E.W. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19 (2006) 491-511
61. Metz-Boutigue M.-H., Jollès J., Mazurier J., Shoentgen F., Legrand D., Spik G., Montreuil J., and Jollès P. Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur. J. Biochem. 145 (1984) 659-676
62. Pentecost B.T., and Teng C.T. Lactotransferrin is the major estrogen inducible protein of mouse uterine secretions. J. Biol. Chem. 262 (1987) 10134-10139
63. Anderson B.F., Baker H.M., Dodson E.J., Norris G.E., Rumball S.V., Waters J.M., and Baker E.N. Structure of human lactoferrin at 3.2-Å resolution. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 1769-1773
64. Spik G., Coddeville B., and Montreuil J. Comparative study of the primary structures of sero-, lacto- and ovotransferrin glycans from different species. Biochimie 70 (1988) 1459-1469
65. Powell M.J., and Ogden J.E. Nucleotide sequence of human lactoferrin cDNA. Nucleic Acids Res. 18 (1990) 4013
66. Mead P.E., and Tweedie J.W. cDNA and protein sequence of bovine lactoferrin. Nucleic Acids Res. 18 (1990) 7167
67. Willnow T.E., Goldstein J.L., Orth K., Brown M.S., and Herz J. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J. Biol. Chem. 267 (1992) 26172-26180
68. Ziere G.J., van Dijk M.C.M., Bijsterbosch M.K., and van Berkel T.J.C. Lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues. J. Biol. Chem. 267 (1992) 11229-11235
69. Ward P.P., Lo J.-Y., Duke M., May G.S., Headon D.R., and Conneely O.M. Production of biologically active recombinant human lactoferrin in Aspergillus oryzae. Biotechnology 10 (1992) 784-789
70. He J., and Furmanski P. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature 373 (1995) 721-724
71. Moore S.A., Anderson B.F., Groom C.R., Haridas M., and Baker E.N. Three-dimensional structure of diferric bovine lactoferrin at 2.8 Å resolution. J. Mol. Biol. 274 (1997) 222-236
72. Hwang P.M., Zhou N., Shan X., Arrowsmith C.H., and Vogel H.J. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry 37 (1998) 4288-4298
73. Ward P.P., Mendoza-Meneses M., Cunningham G.A., and Conneely O.M. Iron status in mice carrying a targeted disruption of lactoferrin. Mol. Cell. Biol. 23 (2003) 178-185
74. Velliyagounder K., Kaplan J.B., Furgang D., Legarda D., Diamond G., Parkin R.E., and Fine D.H. One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis. Infect. Immun. 71 (2003) 6141-6147
75. Hunter H.N., Demcoe A.R., Jenssen H., Gutteberg T.J., and Vogel H.J. Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent. Antimicrob. Agents Chemother. 49 (2005) 3387-3395